Other FDA-approved obesity medications with different mechanisms of actionsuch as semaglutide 2.4 mg (Wegovy), liraglutide 3 mg (Saxenda), phentermine-topiramate, naltrexone-bupropion, orlistat, or setmelanotide for specific genetic obesity syndromesmay be considered
Those who accept that this is a supportive tool not a magic bullet and are willing to pay for clinician supervision, quality sourcing, lab monitoring
Study found that increasing endogenous and exogenous intestinal SCFAs can stimulate intestinal endocrine cells to secrete GLP-1 and PYY by binding to GPR41 and GPR43 (Tian et al., 2024)
Efforts also should be directed toward developing formulations that enhance the bioavailability of GPS(Mudri et al., 2025
Gonzalez Trotter, D
Whether an insurance plan covers the cost of semaglutide injections depends on several factors, including the type of insurance, the reason for the prescription, and the specific terms of the plan